List of insiders holdings for ROCKWELL MEDICAL INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| CHIOINI ROBERT L Chairman, President and CEO | 2017-12-29 16:03:02 | 5,291,574 0 | 5,291,574 | Form 13D |
| HAGELSTEIN DAVID A 10% Owner | 2013-08-13 11:17:57 | 1,991,593 0 | 1,991,593 | Form 13D |
| KLEMA THOMAS E Vice President, CFO | 2017-12-19 17:51:08 | 671,492 0 | 671,492 | Form 4 |
| Gupta Ajay Sr. VP & Chief Scientific Off. | 2020-04-27 14:37:36 | 574,700 0 | 574,700 | Form 4 |
| RAVICH MARK H Director | 2023-05-25 16:14:45 | 303,319 244,905 | 548,224 | Form 4 |
| RAVICH MARK H Norman J. Ravich Irrevocable Trust Norman & Sally Ravich Family Trust Alexander Coleman Ravich 1991 Irrevocable Trust Alyssa Danielle Ravich 1991 Irrevocable Trust See Footnote 1 | 2017-05-23 17:50:37 | 314,750 104,400 | 419,150 | Form 4 |
| Paul Stuart M Chief Executive Officer | 2019-09-06 16:09:40 | 330,056 0 | 330,056 | Form 4 |
| MCLAUGHLIN JOHN PETER Director | 2021-06-22 17:25:14 | 209,831 0 | 209,831 | Form 4 |
| ELLISON RUSSELL H See Remarks | 2021-06-03 16:50:26 | 200,000 0 | 200,000 | Form 4 |
| Smith Angus W. Chief Financial Officer | 2019-11-29 16:05:25 | 168,486 0 | 168,486 | Form 4 |
| COOPER JOHN G Director | 2023-05-25 16:12:54 | 155,594 0 | 155,594 | Form 4 |
| Strobeck Mark President and CEO | 2024-03-19 16:33:07 | 149,364 0 | 149,364 | Form 4 |
| Radie Robert S Director | 2023-05-25 16:19:26 | 134,404 0 | 134,404 | Form 4 |
| Nissenson Allen Director | 2023-05-25 16:18:11 | 124,203 0 | 124,203 | Form 4 |
| Smiley Andrea Heslin Director | 2023-05-25 16:23:08 | 118,316 0 | 118,316 | Form 4 |
| Pratt Raymond Dennis Chief Development Officer | 2021-06-03 16:49:12 | 112,500 0 | 112,500 | Form 4 |
| Kausz Annamaria T VP of Drug Development | 2011-09-26 16:22:22 | 100,000 0 | 100,000 | Form 4 |
| Richmond David S. RBI Private Investment I LLC RBI Private Investment II LLC RBI OPPORTUNITIES FUND LLC RBI OPPORTUNITIES FUND II LLC RBI PI Manager LLC Richmond Brothers 401(k) Profit Sharing Plan Richmond Brothers Inc. Curfman Matthew J. See Footnotes 1 and 2 10% Owner | 2023-09-06 16:49:44 | 84,438 0 | 84,438 | Form 13D |
| Neri Jesse SVP, FINANCE | 2024-03-15 16:35:39 | 80,520 0 | 80,520 | Form 4 |
| SKIBSTED RUSSELL See Remarks | 2022-09-13 16:30:20 | 80,000 0 | 80,000 | Form 4 |
| TIMMINS MEGAN C. EVP, CLO and Secretary | 2024-03-19 16:30:50 | 75,378 0 | 75,378 | Form 4 |
| Yocum Richard C VP - Clin. Dev. & Med. Affairs | 2010-01-19 17:03:39 | 75,000 0 | 75,000 | Form 4 |
| McGarry Paul E SVP, Finance and CAO | 2023-03-21 18:33:34 | 65,725 0 | 65,725 | Form 4 |
| Hoffman Marc L Chief Medical Officer | 2023-03-21 18:39:02 | 58,655 0 | 58,655 | Form 4 |
| Smith Robin L Director | 2019-06-10 19:09:14 | 53,827 0 | 53,827 | Form 4 |
| Lau Joan Director | 2024-02-06 18:56:14 | 52,000 0 | 52,000 | Form 4/A |
| Wolin Benjamin Director | 2019-06-10 19:21:29 | 50,171 0 | 50,171 | Form 4 |
| COLLERAN LISA N Director | 2019-06-10 19:12:44 | 41,135 0 | 41,135 | Form 4 |
| BOYD RONALD D Director | 2018-03-21 17:55:50 | 36,139 0 | 36,139 | Form 4 |
| Bagley Patrick J Director | 2018-03-21 17:54:49 | 32,724 0 | 32,724 | Form 4 |
| Kull David Principal Accounting Officer | 2019-04-30 16:30:47 | 29,270 0 | 29,270 | Form 4 |
| HOLT KENNETH L Director | 2017-03-20 17:46:23 | 12,630 0 | 12,630 | Form 4 |